Stock Screeners / Overvalued Stocks
Fair Value Downside

Overvalued Stocks

Stocks trading above their estimated fair value, useful for risk review and valuation discipline.

3,269 matching stocks · metric: Fair Value Downside
Strong favorable Favorable Watch Risk / negative Neutral
Company Ticker Market Fair Value Downside Fair Value Analyst Upside P/E Dividend Yield Health
Ryde Group Ltd (RYDE) Industrials · Ground Transportation RYDE NYSE -35.0% Downside -35.0% Downside Overvalued -8.8x 0.0% Weak
Twelve Seas Investment Company III (TWLV) Financials · Capital Markets TWLV NASDAQ -35.0% Downside -35.0% Downside Overvalued 161.3x 0.0% Fair
Cantor Equity Partners IV Inc (CEPF) Financials · Capital Markets CEPF NASDAQ -35.0% Downside -35.0% Downside Overvalued 58.0x 0.0% Fair
ETAO International Co Ltd (ETAOF) Financials · Capital Markets MCAG OTC -35.0% Downside -35.0% Downside Overvalued -104.8x 0.0% Fair
IB Acquisition Corp (IBAC) Financials · Capital Markets IBAC NASDAQ -35.0% Downside -35.0% Downside Overvalued 54.8x 0.0% Weak
Piermont Valley Acquisition Corp Unit (CMCUF) Financials · Capital Markets CMCU.F OTC -34.9% Downside -34.9% Downside Overvalued -38.6x 0.0% Good
Chenghe Acquisition III Co (CHEC) Financials · Capital Markets CHEC NASDAQ -34.9% Downside -34.9% Downside Overvalued 88.3x 0.0% Fair
Centaurus Energy Inc (CTARF) Energy · Oil, Gas & Consumable Fuels CTAR.F OTC -34.9% Downside -34.9% Downside Overvalued -82.8x 0.0% Fair
CO2 Energy Transition Corp (NOEM) Financials · Capital Markets NOEM NASDAQ -34.9% Downside -34.9% Downside Overvalued 65.3x 0.0% Fair
StoneBridge Acquisition II Corp (APAC) Financials · Capital Markets APAC NASDAQ -34.9% Downside -34.9% Downside Overvalued 118.4x 0.0% Fair
Mitsui Mining and Smelting Co Ltd ADR (MMSMY) Materials · Metals & Mining MMSM.Y OTC -34.9% Downside -34.9% Downside Overvalued 18.8x 0.0% Great
GSR IV Acquisition Corp (GSRF) Financials · Capital Markets GSRF NASDAQ -34.9% Downside -34.9% Downside Overvalued 74.4x 0.0% Fair
Origin Investment Corp I (ORIQ) Financials · Capital Markets ORIQ NASDAQ -34.9% Downside -34.9% Downside Overvalued 82.4x 0.0% Fair
Collective Mining Ltd (CNL) Materials · Metals & Mining CNL NYSE -34.9% Downside -34.9% Downside Overvalued 97.6% Upside -25.5x 0.0% Fair
Glaukos Corp (GKOS) Healthcare · Healthcare Equipment & Supplies GKOS NYSE -34.9% Downside -34.9% Downside Overvalued 6.7% Upside -47.6x 0.0% Good
Mayville Engineering Co Inc (MEC) Industrials · Machinery MEC NYSE -34.9% Downside -34.9% Downside Overvalued 19.3% Upside -47.9x 0.0% Weak
Trio-Tech International (TRT) Information Technology · Semiconductors & Semiconductor Equipment TRT NYSE -34.8% Downside -34.8% Downside Overvalued 349.5x 0.0% Fair
Jackson Acquisition Company II (JACS) Financials · Capital Markets JACS NYSE -34.8% Downside -34.8% Downside Overvalued 35.7x 0.0% Fair
Quetta Acquisition Corp Unit (QETAU) Financials · Capital Markets QETA.U NASDAQ -34.8% Downside -34.8% Downside Overvalued -71.3x 0.0% Fair
NewcelX AG (NCEL) Healthcare · Biotechnology NCEL NASDAQ -34.8% Downside -34.8% Downside Overvalued 505.6% Upside -2.5x 0.0% Fair
CECO Environmental Corp (CECO) Industrials · Machinery CECO NASDAQ -34.8% Downside -34.8% Downside Overvalued 37.3% Upside 349.1x 0.0% Fair
D Boral ARC Acquisition I Corp (BCAR) Financials · Capital Markets BCAR NASDAQ -34.8% Downside -34.8% Downside Overvalued 70.7x 0.0% Fair
Denali Therapeutics Inc (DNLI) Healthcare · Biotechnology DNLI NASDAQ -34.8% Downside -34.8% Downside Overvalued 46.0% Upside -7.4x 0.0% Fair
SpyGlass Pharma Inc (SGP) Healthcare · Pharmaceuticals SGP NASDAQ -34.7% Downside -34.7% Downside Overvalued 115.2% Upside -15.6x 0.0% Good

Ryde Group Ltd (RYDE)

NYSE · RYDE

Fair Value Downside
-35.0% Downside
Fair Value
-35.0% DownsideOvervalued
P/E
-8.8x
Health
Weak
Fair Value Downside
-35.0% Downside
Fair Value
-35.0% DownsideOvervalued
P/E
54.8x
Health
Weak

Glaukos Corp (GKOS)

NYSE · GKOS

Fair Value Downside
-34.9% Downside
Fair Value
-34.9% DownsideOvervalued
P/E
-47.6x
Health
Good

NewcelX AG (NCEL)

NASDAQ · NCEL

Fair Value Downside
-34.8% Downside
Fair Value
-34.8% DownsideOvervalued
P/E
-2.5x
Health
Fair
Fair Value Downside
-34.7% Downside
Fair Value
-34.7% DownsideOvervalued
P/E
-15.6x
Health
Good